arrow
F

Francesca Kinsella

University of Birmingham
H指数:11
被引数:500

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Correction: Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party

纠正:基于体内T细胞清除(ATG与alemtuzumab)的GVHD预防方案比较,用于接受异基因造血干细胞移植的AML患者,移植预处理强度为中等强度方案:代表EBMT急性白血病工作组进行的登记研究

2026-10-230
OAAI
GvHD prophylaxis in elderly patients: post-transplant cyclophosphamide or ATG? A study by the EBMT transplant complications working party

老年患者移植排斥反应预防:移植后环磷酰胺还是抗胸腺细胞球蛋白?EBMT移植并发症工作组研究

2026-10-060
PRE
Comparison of GvHD prophylaxis regimens based on in vivo T-cell depletion (ATG vs. alemtuzumab) in patients with AML undergoing allo-HCT from unrelated donors with intermediate transplant conditioning intensity protocols: a registry study on behalf of the EBMT acute leukemia working party

基于体内T细胞清除(ATG与alemtuzumab)的GVHD预防方案比较:在异基因无关供者移植且采用中间强度预处理方案的患者中治疗AML的登记研究——代表EBMT急性白血病工作组

2026-09-100
OAAI
A holistic prognostic model for leukemia-free survival after allogeneic transplantation in acute leukemia

异基因移植后急性白血病患者无白血病生存的综合性预后模型

2026-07-020
OA
Trends in Transplantation for Myelodysplastic Syndrome Patients Across Recent Decades: A Registry-Based Study on Behalf of the Chronic Malignancies Working of the EBMT

近年来骨髓增生异常综合征患者移植趋势:EBMT慢性恶性疾病工作组登记研究

2026-05-280
OAAI
Severe Toxic Epidermal Necrolysis Following Combination Ipilimumab-Nivolumab Therapy for Pleural Mesothelioma, Successfully Treated With Ruxolitinib – A Case Report

恶性胸膜间皮瘤患者接受伊匹木单抗联合纳武利尤单抗治疗后发生严重中毒性表皮坏死松解症,并成功使用鲁索利替尼治疗——病例报告

2026-04-110
PRE
Chronic graft-versus-host disease: Current situation and unmet needs — A European position statement

慢性移植物抗宿主病:现状与未满足的需求——欧洲立场声明

2026-03-070
PRE
Allogeneic stem cell transplantation for major T-cell lymphoma entities: an analysis of the EBMT-lymphoma working party

异基因干细胞移植治疗主要T细胞淋巴瘤实体:EBMT淋巴瘤工作组分析

2026-02-210
OAAI
Interindividual HLA evolutionary divergence in mismatched unrelated donor allo-HCT for malignant hematological disorders

不同个体HLA在错配无关供者allo-HCT治疗恶性血液病中的进化分歧

2026-01-010
OA
Quantifying the Clinical and Economic Burden of Graft-Versus-Host Disease Following Allogeneic Haematopoietic Stem Cell Transplantation in England: A Retrospective Cohort Study

量化异基因造血干细胞移植后移植物抗宿主病的临床和经济负担:一项回顾性队列研究

2025-10-060
PRE
Measure selection for an electronic patient-reported outcome (ePRO) system for CAR T-cell therapy patients: a modified Delphi consensus study

电子患者报告结局(ePRO)系统在CAR T细胞治疗患者中的应用:一项改良德尔菲共识研究

2025-06-010
OA
Examining the effect of intermittent cycling throughout a 3-h period on peripheral blood concentrations of haemopoietic stem and progenitor cells and cytolytic natural killer cells

考察在3小时期间内间歇性骑行对造血干细胞和祖细胞以及细胞毒性自然杀伤细胞的外周血浓度的影响

2025-03-280
OA
A comparison of Cryopreserved and non-Cryopreserved Peripheral Blood Hematopoietic Stem Cells for Autologous Transplantation in Multiple Myeloma: A study from the Chronic Malignancies Working Party of the EBMT

比较冷冻保存与非冷冻保存的外周血造血干细胞在多发性骨髓瘤自体移植中的应用:EBMT慢性恶性疾病工作组的研究

2025-03-070
PRE